ArticleActa pharmaceutica Sinica. B2025

Discovery and mechanism verification of first-in-class hydrophobic tagging-based degraders of HBV core protein.

Shujing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.